Cross-Sectional Survey on the Current Role of Clinical Pharmacists among Antimicrobial Stewardship Programmes in Catalonia: Much Ado about Nothing.
antimicrobial stewardship
days of treatment
defined daily doses
information technology
pharmacy
prospective audit and feedback
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
06 Apr 2023
06 Apr 2023
Historique:
received:
17
03
2023
revised:
31
03
2023
accepted:
03
04
2023
medline:
28
4
2023
pubmed:
28
4
2023
entrez:
28
4
2023
Statut:
epublish
Résumé
Antimicrobial resistance killed 1.27 million people in 2019, so urgent actions are desperately needed. Antimicrobial stewardship programmes (ASPs) are essential to optimize antimicrobial use. The objective was to acknowledge the current role of clinical pharmacists engaged in ASP activities in Catalonia. This was a cross-sectional survey shared through the Catalan Infection Control Programme (VINCat). The survey consisted of four sections and was sent by e-mail. A total of 69.0% of the centres answered. Pharmacists dedicated a median of 5.0 h per week (2.1 h/week/100 acute care beds), representing 0.15 full time equivalents. The ASP lacked information technology (IT) support, as only 16.3% of centres automatically calculated defined daily doses and days of therapy. Those with less than 15% of their time available for ASPs conducted fewer clinical activities, especially prospective audits and feedback. Those without official infectious diseases training also performed fewer clinical activities, but training was less determinant than IT support or time. Pharmacists performed interventions mostly through annotation in the medical records. Clinical pharmacists from Catalonia dedicated to ASPs present an important lack of time and IT support to perform clinical activities. Pharmacists should also improve their clinical skills and try to conduct clinical advice to prescribers, either by phone or face-to-face.
Sections du résumé
BACKGROUND
BACKGROUND
Antimicrobial resistance killed 1.27 million people in 2019, so urgent actions are desperately needed. Antimicrobial stewardship programmes (ASPs) are essential to optimize antimicrobial use. The objective was to acknowledge the current role of clinical pharmacists engaged in ASP activities in Catalonia.
METHODS
METHODS
This was a cross-sectional survey shared through the Catalan Infection Control Programme (VINCat). The survey consisted of four sections and was sent by e-mail.
RESULTS
RESULTS
A total of 69.0% of the centres answered. Pharmacists dedicated a median of 5.0 h per week (2.1 h/week/100 acute care beds), representing 0.15 full time equivalents. The ASP lacked information technology (IT) support, as only 16.3% of centres automatically calculated defined daily doses and days of therapy. Those with less than 15% of their time available for ASPs conducted fewer clinical activities, especially prospective audits and feedback. Those without official infectious diseases training also performed fewer clinical activities, but training was less determinant than IT support or time. Pharmacists performed interventions mostly through annotation in the medical records.
CONCLUSIONS
CONCLUSIONS
Clinical pharmacists from Catalonia dedicated to ASPs present an important lack of time and IT support to perform clinical activities. Pharmacists should also improve their clinical skills and try to conduct clinical advice to prescribers, either by phone or face-to-face.
Identifiants
pubmed: 37107079
pii: antibiotics12040717
doi: 10.3390/antibiotics12040717
pmc: PMC10135239
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Antimicrob Chemother. 2018 Mar 1;73(3):804-813
pubmed: 29237051
Enferm Infecc Microbiol Clin. 2010 Nov;28 Suppl 4:36-9
pubmed: 21458699
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
Antimicrob Steward Healthc Epidemiol. 2022 Feb 15;2(1):e24
pubmed: 36310809
Clin Infect Dis. 2022 Nov 30;75(11):2038-2044
pubmed: 35758333
Infect Control Hosp Epidemiol. 2016 Jul;37(7):753-4
pubmed: 27072411
Open Forum Infect Dis. 2016 Oct 15;3(4):ofw210
pubmed: 27844028
Int J Antimicrob Agents. 2019 Sep;54(3):338-345
pubmed: 31200022
Clin Microbiol Infect. 2017 Nov;23(11):785-787
pubmed: 28778544
Clin Microbiol Infect. 2020 Mar;26(3):358-365
pubmed: 31323260
Lancet Infect Dis. 2016 Jul;16(7):847-856
pubmed: 26947617
Med Mal Infect. 2020 Aug;50(5):414-422
pubmed: 31575446
J Antimicrob Chemother. 2015 Apr;70(4):1245-55
pubmed: 25527272
Enferm Infecc Microbiol Clin. 2012 Jan;30(1):22.e1-22.e23
pubmed: 22178010
Antimicrob Agents Chemother. 2016 Jul 22;60(8):4840-52
pubmed: 27246783
Antimicrob Agents Chemother. 2018 Mar 27;62(4):
pubmed: 29339385
Enferm Infecc Microbiol Clin. 2011 Jan;29(1):19-25
pubmed: 21251730
Clin Infect Dis. 2018 Sep 28;67(8):1168-1174
pubmed: 29590355
Am J Health Syst Pharm. 2010 Apr 1;67(7):575-7
pubmed: 20237387
Antibiotics (Basel). 2020 Dec 24;10(1):
pubmed: 33374393
Infect Control Hosp Epidemiol. 2020 Jan;41(1):102-112
pubmed: 31727195
Infect Dis Clin North Am. 2020 Mar;34(1):31-49
pubmed: 31836327
Clin Microbiol Infect. 2020 Dec;26(12):1638-1643
pubmed: 32771646
Sci Rep. 2022 Jan 18;12(1):913
pubmed: 35042878